SEC Comment Letter 0000000000-23-003432 to MARINUS PHARMACEUTICALS, INC. (MRNS) (CIK 0001267813)
MARINUS PHARMACEUTICALS, INC. (MRNS) (CIK 0001267813)
Date: April 5, 2023 · CIK: 0001267813 · Accession: 0000000000-23-003432
AI Filing Summary & Sentiment
File numbers found in text: 333-271041
Show Raw Text
United States securities and exchange commission logo
April 5, 2023
Martha Manning, Esq.
General Counsel
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center, Suite 500
100 Matsonford Rd
Radnor, Pennsylvania 19087
Re:Marinus Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed March 31, 2023
File No. 333-271041
Dear Martha Manning:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen M. Nicolai, Esq.